Nexgel Inc reports results for the quarter ended March 31 - Earnings Summary

• Nexgel Inc NXGL.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -14 cents. The lone analyst forecast for the quarter was for a loss of 10 cents per share.

• Revenue rose 121.6% to $2.81 million from a year ago; analysts expected $2.73 million.

• Nexgel Inc's reported EPS for the quarter was a loss of 9 cents​.

• The company reported a quarterly loss of $712 thousand.

• Nexgel Inc shares had fallen by 8.7% this quarter and lost 39.0% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

This summary was machine generated from LSEG data May 13 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)